KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Elanco Animal Health (ELAN) Accumulated Depreciation & Amortization (2017 - 2025)

Elanco Animal Health's Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $662.0 million for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization fell 4.61% year-over-year to $662.0 million; the TTM value through Dec 2024 reached $662.0 million, down 4.61%, while the annual FY2024 figure was $662.0 million, 4.61% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $662.0 million at Elanco Animal Health, down from $694.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $716.0 million in Q4 2021 and bottomed at $82.0 million in Q1 2020.
  • The 5-year median for Accumulated Depreciation & Amortization is $372.0 million (2021), against an average of $409.1 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization soared 146.34% in 2021 before it fell 12.87% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $517.0 million in 2020, then surged by 38.49% to $716.0 million in 2021, then fell by 4.75% to $682.0 million in 2022, then rose by 1.76% to $694.0 million in 2023, then dropped by 4.61% to $662.0 million in 2024.
  • Per Business Quant, the three most recent readings for ELAN's Accumulated Depreciation & Amortization are $662.0 million (Q4 2024), $694.0 million (Q4 2023), and $173.0 million (Q1 2023).